Epigenetic inhibitors

Mukesh Verma1, Hirendra Nath Banerjee

  • 1Methods and Technologies Branch, Epidemiology and Genomics Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, National Institutes of Health, Rockville, MD, 20852, USA.

Insights

Epigenetic inhibitors offer a novel approach to cancer treatment by reversing gene expression changes without altering DNA sequences. These drugs show promise in reactivating tumor suppressor genes and inhibiting cancer cell growth.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Cancer involves epigenetic changes like DNA methylation and histone deacetylation, which can silence tumor suppressor genes.
  • Epigenetic modifications are dynamic and reversible, offering therapeutic targets.
  • Traditional cancer treatments include chemotherapy, radiation, and surgery.

Purpose of the Study:

  • To explore the mechanisms and therapeutic potential of epigenetic inhibitors in cancer treatment.
  • To review approved epigenetic inhibitors and their applications.
  • To identify challenges in the field, such as lack of specificity.

Main Methods:

  • Review of scientific literature on epigenetic inhibitors and cancer.
  • Analysis of mechanisms of action for DNA methylation and histone deacetylase inhibitors.
  • Discussion of clinical applications and approved drugs.

Main Results:

  • Epigenetic inhibitors can reverse aberrant gene expression linked to cancer.
  • Drugs targeting DNA methylation and histone deacetylation show efficacy in preclinical and clinical studies.
  • Several epigenetic inhibitors are approved for cancer therapy, often used in combination treatments.

Conclusions:

  • Epigenetic inhibitors represent a promising therapeutic strategy for cancer.
  • Reactivation of tumor suppressor genes and repression of cancer cell growth are key outcomes.
  • Improving the specificity of epigenetic inhibitors remains a critical challenge for future development.

Related Concept Videos

Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
11.7K
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
4.3K
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
34.6K
Epigenetic Regulation01:46

Epigenetic Regulation

26.8K
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These...
97
Enzyme Inhibition01:30

Enzyme Inhibition

Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
95.5K